CN104606389A - Medicament for treating face furunculosis - Google Patents

Medicament for treating face furunculosis Download PDF

Info

Publication number
CN104606389A
CN104606389A CN201310567919.4A CN201310567919A CN104606389A CN 104606389 A CN104606389 A CN 104606389A CN 201310567919 A CN201310567919 A CN 201310567919A CN 104606389 A CN104606389 A CN 104606389A
Authority
CN
China
Prior art keywords
parts
medicament
furunculosis
treating face
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310567919.4A
Other languages
Chinese (zh)
Inventor
王芳
陈冠卿
陈洪涛
陈洪波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310567919.4A priority Critical patent/CN104606389A/en
Publication of CN104606389A publication Critical patent/CN104606389A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Disclosed is a medicament for treating face furunculosis, which belongs to the technical field of a traditional Chinese medicine preparation. The medicament is mainly composed of 12 kinds of raw herbs of honeysuckle flower, wild chrysanthemum flower, viola yedoensis, semiaquilegia root, coptis, scutellaria baicalensis, dahurian angelica root, Chinese honey locust spine, and the like. The raw herbs are prepared into medicaments with various kinds of dosage forms such as capsules, tablets and oral liquid by pharmaceutical equipment for standby application. The medicament in the invention has the efficacy of clearing heat and detoxifying, activating blood and relieving pain, and dispersing swelling and expelling pus, and has good effect on treating face furunculosis, safety and no toxic or side effect.

Description

A kind of medicine for the treatment of facial area furuncle
Technical field
The invention belongs to technical field of traditional Chinese medicine preparation.
Background technology
Facial area furuncle, before being mainly in volume, the position such as cheekbone, cheek, nose, lip, starting on skin, have a Semen setariae sample skin ulcer head, or itches or fiber crops, later red and swollen heat pain gradually, more than lump scope 1-2 cun, and Top root of dashing forward is deeply hard.Between about 5-7 day, the soft routed pus of Top coca, furuncle root is gone out with pus, and soon the swollen pain that disappears only heals.The severe one initial stage can with fever with aversion to cold, and mid-term is thirsty with heating, and constipation is urinated red, yellow and greasy fur, forceful pulse number.Modern medicine to this treatment demonstrate,proved generally based on antibiotic.But in recent years due to abuse of antibiotics, pathogenic bacteria is developed immunity to drugs, add treatment difficulty and side effect.
Summary of the invention
The object of the invention is to overcome the deficiencies in the prior art, a kind of medicine for the treatment of facial area furuncle is provided.It has heat-clearing and toxic substances removing, promoting blood circulation and stopping pain, effect of detumescence and apocenosis, and treatment facial area furuncle is effective.Determined curative effect can be reached, the object of safe without toxic side effect.
The technical solution adopted for the present invention to solve the technical problems is: be made up of Flos Lonicerae, Flos Chrysanthemi Indici, Herba Taraxaci, Herba Violae, Radix Semiaquilegiae, Rhizoma Coptidis, Radix Scutellariae, Cortex Phellodendri, Fructus Gardeniae, the Radix Angelicae Dahuricae, Folium Isatidis, Spina Gleditsiae 12 kinds of crude drug.
About ingredient major function and preparation in invention formulation.
Flos Lonicerae in the present invention, nature and flavor are sweet, cold.Containing Flos Lonicerae glycoside, inositol, Saponin etc.Heat-clearing and toxic substances removing.Cure mainly epidemic febrile disease heating, carbuncle, scabies, malignant boil, toxic swelling, toxic-heat and blood stasis, pneumonia, laryngopharynx swelling and pain, anemopyretic cold etc.
Flos Chrysanthemi Indici in the present invention, nature and flavor are bitter, pungent, are slightly cold.Heat-clearing and toxic substances removing.Cure mainly carbuncle, furunculosis, laryngopharynx swelling and pain, wind-fire acute conjunctivitis, skin pruritus etc.
Herba Taraxaci in the present invention, nature and flavor are bitter, sweet, cold.Containing taraxasterol, taraxacin, glucose, pectin, choline, caffeic acid etc.Heat-clearing and toxic substances removing, eliminating stagnation.Cure mainly taste stagnated fire, acute mastitis, scrofula, pyretic stranguria, lymphadenitis.
Herba Violae in the present invention.Nature and flavor are bitter, cold.Containing glycoside, flavonoid, wax etc.Heat-clearing and toxic substances removing.Cure mainly ulcer sores, scrofula malignant boil.
Radix Semiaquilegiae in the present invention, nature and flavor are sweet, bitter, cold.Slightly poisonous.Heat-clearing and toxic substances removing, inducing diuresis to remove edema.Cure mainly furuncle furuncle and phyma, mastitis, tonsillitis, lymphoid tuberculosis, hernia, dysuria, traumatic injury, venom.
Rhizoma Coptidis in the present invention, nature and flavor are bitter, cold.Containing 13-methyl-.psi.-coptisine., Palmic acid etc.Pathogenic fire purging dampness, relieving restlessness is detoxified.Curing mainly Hot contains vexed, and feeling of fullness, quenches one's thirst, and Hot dysentery is suffered from abdominal pain, tenesmus, conjunctival congestion and swelling pain, skin sore, aphtha.
Radix Scutellariae in the present invention, nature and flavor are bitter, cold.Containing baicalin, wogonoside, glucuronic acid, enzyme etc.Clearing away damp-heat, purte the white, antiabortive removing toxic substances.Cure mainly jaundice due to damp-heat, cough due to lung-heat, ulcer sores, frequent fetal movement.
Cortex Phellodendri in the present invention, nature and flavor are bitter, cold.Containing phellodendrine, Palmic acid, fatty oil, obacunone, phlegmatic temperament, sterol etc.Reducing the minister-fire, except damp and hot.Cure mainly aphtha of the mouth and tongue, conjunctival congestion tinnitus, Hot dysentery is had loose bowels, osteopyrexia and fever, jaundice, and stranguria with turbid discharge is had blood in stool, leucorrhea with red and white discharge, noxious dampness skin infection.
Fructus Gardeniae in the present invention, nature and flavor are bitter, cold.Containing gardenoside, flavochrome, amaroid, quintessence oil, mannitol, choline, tannin etc.Heat clearing away, diuresis, removing heat from blood.Cure mainly calentura dysphoria and insomnia, thirsty, pharyngalgia, conjunctival congestion, jaundice, five types of stranguria, spit blood, epistaxis, dysentery is had blood in stool.External treatment traumatic injury, dampens, swells and ache.
The Radix Angelicae Dahuricae in the present invention, nature and flavor are pungent, temperature.Containing Radix Angelicae Dahuricae element, Radix Angelicae Dahuricae ether, phellopterin.Expelling pathogenic wind and eliminating dampness, promoting blood circulation and stopping pain, granulation promoting evacuation of pus.Cure mainly flu headache, supraorbital pain, toothache, nasal sinusitis, hemorrhoidal hamorrhage anal fistula, leucorrhea with red and white discharge, carbuncle epidemic disease poison, skin pruritus.
Folium Isatidis in the present invention, nature and flavor are bitter, cold.Containing indigo glycoside.Heat-clearing and toxic substances removing, removing heat from blood is subsided a swelling.Cure mainly epidemic disease pyretic toxicity, macule, pestilence, erysipelas, laryngopharynx swelling and pain, acute infectious hepatitis, bacillary dysentery, acute gastroenteritis, acute pneumonia, spit blood, epistaxis, aphtha, skin sore.
Spina Gleditsiae in the present invention, nature and flavor are pungent, temperature.Containing flavonoid glycoside, phenols, aminoacid.Search wind, parasite killing, poison holding, carbuncle of bursting.Cure mainly carbuncle, sore, malignant boil swells and ache non-Collapse, tinea skin ulcer, placenta retention.
The etiology and pathogenesis of facial area furuncle is disease by burning hot poison.Its poison or from interior, or accumulate steaming skin by diseases caused by exogenous pathogenic factor and contamination gained, so that coagulation of QI-blood forms.The present invention has heat-clearing and toxic substances removing, promoting blood circulation and stopping pain, effect of detumescence and apocenosis, and treatment facial area furuncle is effective.The invention has the beneficial effects as follows through clinical practice proof determined curative effect, safe without toxic side effect.
Detailed description of the invention
1. formula and part by weight: Flos Lonicerae 20 parts, Flos Chrysanthemi Indici 16 parts, Herba Taraxaci 20 parts, Herba Violae 18 parts, Radix Semiaquilegiae 12 parts, Rhizoma Coptidis 10 parts, Radix Scutellariae 15 parts, Cortex Phellodendri 12 parts, Fructus Gardeniae 12 parts, the Radix Angelicae Dahuricae 15 parts, Folium Isatidis 30 parts, Spina Gleditsiae 12 parts.
2. manufacture method: weighed in proportion by above-mentioned raw materials medicine and assort, it is qualified to concoct with pharmaceutical equipment apparatus, and purifying, it is for subsequent use to make the different dosage forms such as capsule, tablet, pill, granule, oral liquid after concentrating.

Claims (1)

1. treat a medicine for facial area furuncle, it is characterized in that formula and part by weight are Flos Lonicerae 20 parts, Flos Chrysanthemi Indici 16 parts, Herba Taraxaci 20 parts, Herba Violae 18 parts, Radix Semiaquilegiae 12 parts, Rhizoma Coptidis 10 parts, Radix Scutellariae 15 parts, Cortex Phellodendri 12 parts, Fructus Gardeniae 12 parts, the Radix Angelicae Dahuricae 15 parts, Folium Isatidis 30 parts, Spina Gleditsiae 12 parts; Weighed in proportion by above-mentioned raw materials medicine and assort, it is qualified to concoct with pharmaceutical equipment apparatus, purify concentrated after make capsule, tablet, pill, granule, oral liquid different dosage form are for subsequent use.
CN201310567919.4A 2013-11-04 2013-11-04 Medicament for treating face furunculosis Pending CN104606389A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310567919.4A CN104606389A (en) 2013-11-04 2013-11-04 Medicament for treating face furunculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310567919.4A CN104606389A (en) 2013-11-04 2013-11-04 Medicament for treating face furunculosis

Publications (1)

Publication Number Publication Date
CN104606389A true CN104606389A (en) 2015-05-13

Family

ID=53141209

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310567919.4A Pending CN104606389A (en) 2013-11-04 2013-11-04 Medicament for treating face furunculosis

Country Status (1)

Country Link
CN (1) CN104606389A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105168920A (en) * 2015-09-18 2015-12-23 马鞍山德宏堂生物科技有限公司 Externally applied traditional Chinese medicine for treating furunculosis
CN106074384A (en) * 2016-08-08 2016-11-09 甘肃新天马制药股份有限公司 A kind of pirlimycin micellar preparation and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105168920A (en) * 2015-09-18 2015-12-23 马鞍山德宏堂生物科技有限公司 Externally applied traditional Chinese medicine for treating furunculosis
CN106074384A (en) * 2016-08-08 2016-11-09 甘肃新天马制药股份有限公司 A kind of pirlimycin micellar preparation and preparation method thereof

Similar Documents

Publication Publication Date Title
CN104606385A (en) Traditional Chinese medicine preparation for treating paronychia
CN104606389A (en) Medicament for treating face furunculosis
CN104644891A (en) Felon treating traditional Chinese medicine preparation
CN104644889A (en) Finger pulp pustule treating external application paste
CN104623112A (en) Plaster for treating snake-head furuncle
CN104606350A (en) Medicament for treating throat-blocking abscess
CN104587074A (en) External preparation for treatment of facial furunculosis
CN104623113A (en) Drug for treating snake belly furuncle
CN104623115A (en) Traditional Chinese medicine preparation for treating acute lymphangitis
CN104623111A (en) Drug for treating palmar furuncle
CN102397448A (en) Chinese herbal medicine for treating toothache
CN104644892A (en) Cutaneous anthrax treating drug
CN102670957B (en) Health-care composition and preparation method and application thereof
CN104225293A (en) Traditional Chinese medicine disinfectant solution for clinical laboratory
CN104606401A (en) Medicament for treating umbilical abscess
CN104606330A (en) Traditional Chinese medicine preparation for treating gluteal abscess
CN104688946A (en) Medicine for treating early suppurative osteomyelitis
CN104587021A (en) External application preparation for treatment of umbilical carbuncle
CN105012573A (en) Preparation for treating liver-fire damp-heat type vulval swelling
CN104606387A (en) Poison drawing out ointment
CN106620307A (en) Medicine for treating septic psoriasis
CN104606329A (en) Ointment for treating gluteal abscess
CN105012447A (en) Medicine for treating qi-blood deficiency vulval swelling
CN104644893A (en) Medicine for treating carbuncle complicated by septicemia
CN104940582A (en) Medicament for treating fire invasion type deep-seated sore with internal invasion

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150513

WD01 Invention patent application deemed withdrawn after publication